At 2 years in the FAVOR III Europe trial of 2,000 patients with intermediate coronary stenoses, MACE was 9.7% with QFR-guided vs 7.4% with FFR-guided revascularisation (HR 1.34, 95% CI 0.98-1.81; p=0.064); 1-2 year rates were both 3.2%.
RCTn = 2,000 patients
Andersen et al. Quantitative flow ratio versus fractional flow reserve: 2-year follow-up of the FAVOR III Europe trial